Mesenchymal stem cells (MSC) expansion methods and materials
US-9220810-B2 · Dec 29, 2015 · US
US9260698B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9260698-B2 |
| Application number | US-201414336719-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 21, 2014 |
| Priority date | Mar 5, 2007 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Cell expansion systems and methods of use are provided. The cell expansion systems generally include a hollow fiber cell growth chamber, and first and second circulation loops (intracapillary loops and extracapillary loops) associated with the interior of the hollow fibers and exterior of the hollow fibers, respectively. Detachable flow circuits and methods of expanding cells are also provided.
Opening claim text (preview).
I claim: 1. A method of expanding cells in a detachable flow circuit configured to attach to a fixed portion of a cell expansion system, wherein the cell expansion system comprises an incubator and a plurality of controllers, the method comprising: adding the cells to the detachable flow circuit, wherein the detachable flow circuit comprises: a first fluid circulation path comprising a first fluid flow path having at least opposing ends, a first end of the first fluid flow path configured to fluidly associate with a first inlet port of a cell growth chamber, and a second opposing end of the first fluid flow path configured to fluidly associate with a first outlet port of the cell growth chamber, wherein a portion of the first fluid circulation path is configured to be disposably mounted to a first fluid controller of the fixed portion of the cell expansion system; a second fluid circulation path comprising a second fluid flow path having at least opposing ends, a first end of the second fluid flow path configured to fluidly associate with a second inlet of the cell growth chamber, and a second opposing end of the second fluid flow path configured to fluidly associate with a second outlet of the cell growth chamber, wherein a portion of the second fluid circulation path is configured to be disposably mounted to a second fluid controller of the fixed portion of the cell expansion system; a first fluid connector path having at least opposing ends, a first opposing end of the first fluid connector path fluidly associated with the first fluid circulation path and a second opposing end of the first fluid connector path fluidly associated with the second fluid circulation path, wherein a portion of the first fluid connector path is configured to be disposably mounted to a third fluid controller of the fixed portion of the cell expansion system; and a second fluid connector path having opposing ends, one end of the second fluid connector path fluidly associated with the first fluid flow path and a second end of the second fluid connector path fluidly associated with the second fluid flow path, wherein a portion of the second fluid connector path is configured to be disposably mounted to a fourth fluid controller of the fixed portion of the cell expansion system; and incubating the cells to produce an expanded population of cells. 2. The method of claim 1 , further comprising harvesting at least a portion of the expanded population of cells. 3. The method of claim 1 , wherein the cells comprise stem cells. 4. The method of claim 3 , wherein the stem cells comprise adherent stem cells. 5. The method of claim 3 , wherein the stem cells comprise non-adherent stem cells. 6. The method of claim 1 , wherein the first fluid controller comprises one or more from the group consisting of: a pump, a valve, and a clamp. 7. The method of claim 1 , wherein the second fluid controller comprises one or more from the group consisting of: a pump, a valve, and a clamp. 8. The method of claim 1 , wherein the third fluid controller comprises one or more from the group consisting of: a pump, a valve, and a clamp. 9. The method of claim 1 , wherein the fourth fluid controller comprises one or more from the group consisting of: a pump, a valve, and a clamp. 10. The method of claim 1 , wherein fluid in the first fluid circulation path flows through an intracapillary space of one or more hollow fibers in the cell growth chamber. 11. The method of claim 1 , wherein fluid in the second fluid circulation path flows through an extracapillary space of one or more hollow fibers in the cell growth chamber.
Bone marrow mesenchymal stem cells (BM-MSC) · CPC title
Perfusion · CPC title
Hollow fibers (hollow fiber modules in general B01D63/02) · CPC title
Hollow fibers or tubes (hollow fiber modules in general B01D63/02) · CPC title
Culture process characterised by the use of hydrostatic pressure, flow or shear forces · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.